Inactive Instrument

Cannassure Therapeutics Ltd Stock TEL AVIV STOCK EXCHANGE

Equities

CSURE

IL0001110134

Healthcare Facilities & Services

Sales 2022 33.78 121.66 Sales 2023 11 39.61 Capitalization 4M 14.41M
Net income 2022 -5M -18.01M Net income 2023 -1M -3.6M EV / Sales 2022 1,023,292 x
Net Debt 2022 29.96M 108M Net Debt 2023 2.43M 8.77M EV / Sales 2023 585,038 x
P/E ratio 2022
-0.84 x
P/E ratio 2023
-2.24 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 86.6%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 54 22-03-30
Chairman 51 18-12-03
Comptroller/Controller/Auditor 70 19-06-25
Members of the board TitleAgeSince
Director/Board Member 72 18-12-03
Chairman 51 18-12-03
Director/Board Member 56 22-02-13
More insiders
YB Urban Renewal Residential Development Ltd, formerly known as Cannassure Therapeutics Ltd, is an Israel-based urban renewal company. The Company is engaged mainly in urban renewal projects. In the urban renewal projects sector, the Company partakes in activities that aim to clear out areas of inner cities deemed to be neglected, unused and loosely maintained, in favor of new multifamily housing, business areas, as well as other developments improving the city landscape. The Firm aims to achieve economic, cultural and environmental renewal of the neglected inner city areas. The Company cooperates with a range of specialists in the field of urban renewal with knowledge and experience in urban planning and construction work.
More about the company